Oticon Medical announced that the US Food and Drug Administration (FDA) has cleared the new Ponto 5 SuperPower sound processor, expanding the Ponto 5 family product line. Introducing ‘full SuperPower strength in the smallest SuperPower device ever available, the Ponto 5 SuperPower also delivers significant advancements in sound processor technology – including a patented feature to prevent audible feedback – along with a sleek cosmetic design,” according to the company.
The OpenSound Optimizer technology in the Ponto 5 SuperPower helps “crack the code” of how to prevent feedback. It works by detecting and preventing audible feedback from occurring, rather than managing feedback by reducing amplification, according to Oticon Medical. This helps enables audiologists to fit users with up to 5 dB† of extra stable gain without compromising on the dynamics of sound.1
In addition, the OpenSound Navigator technology gives users access to their “full 360° soundscape, rather than simply focusing on speech as traditional technologies do.” This helps provide users with greater focus and awareness of their surroundings and has been confirmed in a study to significantly improve speech understanding.*2
This combination of unique features works seamlessly across listening environments to deliver breakthrough fuller sound, without the risk of audible feedback.**1
Commenting on the clearance, Jes Olsen, President of Oticon Medical, said, “I’m incredibly proud of this product, and I see the FDA clearance as an acknowledgement of our significant accomplishment and of the ability of this important device to help people with hearing loss. I look forward to our product launch in the near future and to helping even more people get access to powerful sound and the benefits of BrainHearing technology. It represents a major advancement of our mission to empower all users by providing the best possible sound experience.”
As part of the Ponto 5 family, the new Ponto 5 SuperPower is also designed with premium details. These include easy connectivity and streaming, the Oticon RemoteCare platform for access to care from anywhere, as well as the state-of-the-art reliability, durability and product quality that have become synonymous with Ponto, according to the company.
The Ponto 5 SuperPower will become available in the spring of 2022.
1 Data on file at Oticon Medical
2 Data on File – Clinical study BC109
†When measured on Ponto 5 SuperPower relative to Ponto 3 SuperPower
*Increased speech understanding when comparing performance with OpenSound Navigator ON relative to OpenSound Navigator OFF.
** For prescribed fittings, according to best practice and during normal use.
Source: Oticon Medical